Excellagen®
Excellagen® is an Advanced, Wound Care Management Platform
For professional use only; designated as “skin substitutes” per CMS. MAC reimbursement process
• Formulated fibrillar Collagen (2.6%) Wound Conforming Matrix
• High molecular weight
Excellagen® Highlights
Excellagen® is FDA 510(K) cleared for 17 wound types
Intellectual properties and global rights of Excellagen® except China, Russia and CIS
R&D company spent over $20 million prior to approval
Received Patent on October 10, 2017
Has a unique Healthcare Common Procedure Coding System (HCPCS) Code – Q4149 https://hcpcs.codes/q-codes/Q4149/
Clinical data show significant tissue growth, accelerated healing response and positive wound closure
Safe and effective
No mixing, no sutures, no staples, no thawing
Over $20 million invested and completed
Viscosity optimized for dripless wound coverage
Wound Conforming Matrix that completely covers the wound bed and fills all voids
Pre-filled, ready to use syringes with flexible applicator tips
Three syringe sizes: 0.5cc, 0.8cc and 3.0cc to cover a variety of wound sizes
Refrigerated storage
Treatment at only one-week intervals
Immediately activates human platelets triggering release of Platelet-Derived Growth Factor (PDGF) a key
Accelerates granulation tissue growth in “non-healing wounds”
Excellagen® is categorized as Cellular and/or Tissue Based Product (CTP)
Excellagen® Highlights
Excellagen® is FDA 510(K) cleared for 17 wound types
Intellectual properties and global rights of Excellagen® except China, Russia and CIS
R&D company spent over $20 million prior to approval
Received Patent on October 10, 2017
Has a unique Healthcare Common Procedure Coding System (HCPCS) Code – Q4149 https://hcpcs.codes/q-codes/Q4149/
Clinical data show significant tissue growth, accelerated healing response and positive wound closure
Safe and effective
No mixing, no sutures, no staples, no thawing
Over $20 million invested and completed
Viscosity optimized for dripless wound coverage
Wound Conforming Matrix that completely covers the wound bed and fills all voids
Pre-filled, ready to use syringes with flexible applicator tips
Three syringe sizes: 0.5cc, 0.8cc and 3.0cc to cover a variety of wound sizes
Refrigerated storage
Treatment at only one-week intervals
Immediately activates human platelets triggering release of Platelet-Derived Growth Factor (PDGF) a key
Accelerates granulation tissue growth in “non-healing wounds”
Excellagen® is categorized as Cellular and/or Tissue Based Product (CTP)
Additionally,
Excellagen has can serve as an Enabling Delivery Platform for pluripotent stem cells, antimicrobial agents, small molecule drugs, DNA-Based Biologics, conditioned cell media and peptides.
Mission
Future products focusing on innovative therapies in bone and joint regeneration comprise current pipeline. The company’s mission is to become a significant force in regenerative medicine and Innovate the Science of Healing.
Mission
Future products focusing on innovative therapies in bone and joint regeneration comprise current pipeline. The company’s mission is to become a significant force in regenerative medicine and Innovate the Science of Healing.